Dimensional Fund Advisors
CTSO icon

Dimensional Fund Advisors’s Cytosorbents Corp CTSO Stock Holding History

Dimensional Fund Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-56,570
Closed -$62.7K – 3400
2023
Q4 		$62.7K Sell
56,570
-22,888
-29% -$34K ﹤0.01% 3333
2023
Q3 		$149K Sell
79,458
-6,558
-8% -$18.8K ﹤0.01% 3260
2023
Q2 		$309K Hold
86,016
– – ﹤0.01% 3151
2023
Q1 		$290K Sell
86,016
-7,263
-8% -$21.8K ﹤0.01% 3129
2022
Q4 		$144 Sell
93,279
-16,361
-15% -$24.3K ﹤0.01% 3282
2022
Q3 		$149K Sell
109,640
-75,989
-41% -$148K ﹤0.01% 3283
2022
Q2 		$407K Sell
185,629
-59,311
-24% -$136K ﹤0.01% 3108
2022
Q1 		$781K Sell
244,940
-4,735
-2% -$17K ﹤0.01% 3049
2021
Q4 		$1.05M Buy
249,675
+26,819
+12% +$150K ﹤0.01% 3023
2021
Q3 		$1.81M Buy
222,856
+161,369
+262% +$1.31M ﹤0.01% 2882
2021
Q2 		$464K Buy
+61,487
New +$518K ﹤0.01% 3177

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Dimensional Fund Advisors's CTSO Position: Q1 2024 in Review

Dimensional Fund Advisors sold out of Cytosorbents Corp (CTSO) in Q1 2024, closing a stake of 56,570 shares — an estimated $62.7K sold.

Dimensional Fund Advisors first reported a position in CTSO in Q2 2021 and held it in 11 quarters. The position peaked at $1.81M in Q3 2021. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2024.

  • Dimensional Fund Advisors reported no remaining Cytosorbents Corp position as of Q1 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 56,570 Cytosorbents Corp shares in Q1 2024, an estimated $62.7K.
  • Dimensional Fund Advisors first reported a position in Cytosorbents Corp in Q2 2021 and held it in 11 quarters.
  • Dimensional Fund Advisors's Cytosorbents Corp position peaked at $1.81M in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2024.

Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.